OM Pharma
OM Pharma, headquartered in Switzerland (CH), is a prominent player in the biopharmaceutical industry, specialising in innovative therapies for serious diseases. Founded in 1987, the company has established a strong presence in Europe and beyond, focusing on areas such as immunology and infectious diseases. With a portfolio that includes unique biological products and advanced therapies, OM Pharma is dedicated to addressing unmet medical needs. Their commitment to research and development has led to significant milestones, including the successful launch of several key products that enhance patient outcomes. Recognised for its expertise and innovation, OM Pharma continues to strengthen its market position, contributing to advancements in healthcare and improving the lives of patients worldwide.
DitchCarbon Score
How does OM Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OM Pharma's score of 28 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OM Pharma's reported carbon emissions
OM Pharma, headquartered in Switzerland (CH), currently does not report any specific carbon emissions data, as no emissions figures are available. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, OM Pharma has not outlined any reduction targets or initiatives in the provided data. This absence of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, OM Pharma's future climate commitments will be crucial for aligning with global standards and expectations. The company may benefit from adopting frameworks such as the Science Based Targets initiative (SBTi) or participating in initiatives like the Carbon Disclosure Project (CDP) to enhance transparency and accountability in its environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OM Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
